E thehiloe ka 2009, JYMed ke khoebo ea meriana Chaena e kopanyang R&D, tlhahiso, khoebo, nts'etsopele ea moetlo le tlhahiso ea lihlahisoa tsa peptide. Khamphani e na le basebetsi ba ka bang 570, ba nang le sehlopha sa batsamaisi ba mantlha se entsoeng ka litsebi tse nang le boiphihlelo ba meriana le boiphihlelo ba lilemo tse fetang 20 indastering ea peptide. JYMed e sebetsa setsing se le seng sa lipatlisiso le lits'ebeletso tse peli tse kholo tsa tlhahiso, ho fihlela matla a tlhahiso ea lithane tse ngata ho li-peptide, ho e beha joalo ka moetapele oa indasteri.
JYMED
lihlahisoa
Peptide APIs
Peptide APIs
JYMed e fana ka li-portfolio tse fapaneng tsa li-API tsa peptide, ho kenyelletsa le mefuta e fetang 20 e kang Semaglutide, Tirzepatide, Liraglutide, Degarelix, le Oxytocin. Har'a tsena, lihlahisoa tse hlano, tse kenyelletsang Semaglutide le Tirzepatide, li atlehile ho phethahatsa ngoliso ea FDA Drug Master File (DMF).
Cosmetic Peptide
Cosmetic Peptide
JYMed e fana ka li-peptide tsa boleng bo holimo tsa cosmetic, lisebelisoa tse tala, le lits'ebeletso tsa tlhahiso ea OEM ho tloha sehlopheng sa lipatlisiso ho isa sehlopheng sa cGMP, kaofela ka taolo e thata ea boleng. Li-peptide tsa rona tsa maiketsetso, tse tsebahalang ka polokeho ea tsona le boiketlo ba ho fetoloa, ke lisebelisoa tsa bohlokoa indastering ea litlolo, tse fanang ka melemo e netefalitsoeng bakeng sa tlhokomelo ea moriri, pholiso ea maqeba, anti-botsofali, anti-wrinkle, bosoeu le kholo ea lintši.
Tšebeletso ea CRO&CDMO
Tšebeletso ea CRO&CDMO
JYMed e na le sistimi e felletseng ea ts'ebetso ea liindasteri tsa peptide, e fanang ka lits'ebeletso tse felletseng bakeng sa lihlahisoa tsa peptide le peptide-analog, ho kenyeletsoa lipatlisiso le tlhahiso ea li-peptide tsa kalafo, li-peptide tsa bongaka ba liphoofolo, li-peptide tsa litlolo, le RNA, hammoho le ts'ehetso ea ho ngolisoa le ho latela melao. .
Peptide e tloaelehileng
Peptide e tloaelehileng
JYMed e le khoebo e shebaneng le bareki, e na le sistimi e felletseng ea ntlafatso ea li-peptide, e nang le boiphihlelo ba lilemo tse fetang 20 ho peptide R&D le lits'ebeletso tsa morao-rao. Re fana ka mefuta e felletseng ea li-peptide tsa boleng bo holimo tse ipapisitseng le tlhoko ea moreki: Palo ho tloha ho mg ho isa ho kg, bohloeki ho tloha ho tse tala ho isa ho> 99%, ho tloha ho e seng GMP ho ea ho sehlopha sa GMP, ho tloha ho li-peptide tse bonolo ho isa ho li-peptide tse fetotsoeng, nts'etsopele ea antigenic peptides, tumellano ea lekunutu e teng.
MABAPI LE
JYMED
Kenyelletso ea JYMed, e leng US FDA e hlahlobileng moetsi oa peptide. Lihlahisoa tse hlahang: cosemtic peptide, peptide APIs, peptide tloaelo, joalo ka, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8, joalo-joalo Ho tseba haholoanyane, ka kopo ikopanye le
Email: jymed@jymedtech.com
litaba le tlhahisoleseding
Litaba Tse Thabisang | Setsi sa Tlhahiso ea Semaglutide API se Seholo ka ho Fetisisa sa Chaena se Feta Tlhahlobo ea US FDA
Ho tloha ka la 26 Phato ho isa la 30 Phato, 2024, setsi sa tlhahiso ea peptide sa JYMed, Hubei JX Bio-Pharmaceutical Co., Ltd., se atlehile ho fetisa tlhahlobo ea setšeng e entsoeng ke Tsamaiso ea Lijo le Lithethefatsi ea US (FDA). Tlhahlobo e ne e akaretsa likarolo tsa bohlokoa ...
2024 CPHI Milan Pharmaceutical Exhibition Recap
01. Kakaretso ea Lipontšo Ka la 8 Mphalane, Pontšo ea Lefatše Lohle ea Litlhare ea CPHI ea 2024 e qalile Milan. E le e 'ngoe ea liketsahalo tsa bohlokoahali tsa selemo le selemo indastering ea meriana ea lefats'e, e hohetse barupeluoa ba tsoang linaheng le libaka tse 166. Ho feta ...
Litaba Tse Thabisang | JYMed's Liraglutide API e Fumana Setifikeiti sa WC
Ka la 12 Mphalane 2024, JYMed's Liraglutide API e ile ea fumana setifikeiti sa Bopaki bo Ngotsoeng (WC), se tšoaeang mohato oa bohlokoa oa ho romelloa ka katleho ha API 'marakeng oa EU. WC (Tiiso e Ngotsoeng)...
